File: '\\swfile\EmailIn\20240301 135747 Attachment 2024_03_01 TRUE NR option grants.docx'

Treatment.com AI Grants Incentive Stock Options

VANCOUVER, British Columbia, March 1, 2024 - Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the "Company" or "Treatment") announces that the Company has granted 870,000 stock options, exercisable at $0.55 and valid for a five-year term, to officers, directors and consultants of the Company. The stock options are issued pursuant to the Company's stock option plan and are subject to vesting conditions.

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO

ehamza@treatment.com

(612) 788-8900

Toll-free: (888) 788-8955

Cautionary Statements

This news release contains forward-looking statements that are based on Treatment.com's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.